News/Events
Large number of stem cell lines carry significant DNA damage, say researchers
Cambridge researchers say detailed genetic characterisation including whole genome sequencing can help ensure safety of cell-based therapies.Read more
Hundreds more to join Covid study to help protect most at risk
Up to 1,700 more patients from across the UK are being asked to join an Addenbrooke’s led drug trial, to help find ways of protecting those with poor immunity from catching Covid.Read more
Heart surgery delays will cost lives, warns research
Urgent action is needed to clear the backlog of people waiting for treatment for severe aortic stenosis as a result of the Covid-19 pandemic.Read more
Cambridge researchers to receive nearly £4m to tackle cancer roadblocks
NIHR Cambridge BRC researchers are among the Cambridge scientists to receive £3,938,500 as part of Cancer Grand Challenges, a major initiative co-founded by Cancer Research UK and the National Cancer Institute in the Read more
Research reveals how genetic mutations cause kidney cancer
Researchers at the University of Cambridge have shown that genetic mutations associated with kidney cancer rely on factors that regulate normal kidney cells in order to develop into cancer cells.
The study suggests Read more
New genomic testing provides vital diagnosis for severely ill babies
More than a third of severely sick babies referred for rapid whole genome sequencing receive vital genetic diagnosis in latest study. Read more
Cambridge researchers awarded Fellow status
Eight Cambridge researchers are elected as Fellows of the Academy of Medical Sciences.Read more
Celebrating International Clinical Trials Day
Patients, volunteers and research staff share why taking part in research is important and what it means to them.Read more
Funding boost for ‘sponge on a string’ trial
Millions of pounds in funding has been announced for a trial that could pave the way for a ‘sponge on a string’ test to be established as a routine screening programme to detect Barrett’s oesophagus – a condition that can lead to oesophageal cancer. Read more
Cognitive impairment from severe COVID-19 equivalent to 20 years of ageing, research finds
Researchers suggest cognitive impairment as a result of severe COVID-19 is similar to that sustained between 50 and 70 years of age and is the equivalent to losing 10 IQ points.Read more
Children with cancer benefit from whole genome sequencing
More than 100 children with cancer from across the East of England have had their tumours tested by whole genome sequencing to help improve their diagnosis and treatment.Read more
Largest study of whole genome sequencing data reveals new clues to causes of cancer
DNA analysis of thousands of tumours from NHS patients has found a ‘treasure trove’ of clues about the causes of cancer.Read more
Discover more about the NIHR Cambridge BRC
Contact us by phone, email or web for more information.
Events Calendar
Listing relevant events and training sessions for researchers and members of the public.